Mulmit

Immunome Inc.Immunome Inc.

IMNM Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-316,941,000-224,113,000-212,394,000-2.43
2024-12-319,041,000-305,800,000-292,963,000-5
2023-12-3114,018,000-109,530,000-106,806,000-5.38

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-11Higgins JackChief Scientific Officer18,000
2026-09-11Higgins JackChief Scientific Officer13,200
2026-09-11Higgins JackChief Scientific Officer8,800
2026-09-11Higgins JackChief Scientific Officer18,000
2026-08-12Barchas Isaac11,048
2026-08-11Barchas Isaac62,291
2026-08-10Barchas Isaac10,125
2026-08-07Barchas Isaac15,248
2026-08-06Barchas Isaac20,840
2026-08-04Horn KinneyCHIEF BUSINESS OFFICER50,366
2026-08-04Horn KinneyCHIEF BUSINESS OFFICER40,250
2026-08-04Horn KinneyCHIEF BUSINESS OFFICER90,616

8-K events

FiledItems
2026-08-11Results of operations · Financial statements and exhibits
2026-06-12Submission of matters to a vote
2026-05-12Results of operations · Financial statements and exhibits
2026-03-03Results of operations · Financial statements and exhibits
2025-12-17Other events · Financial statements and exhibits
2025-12-15Regulation FD disclosure · Other events · Financial statements and exhibits
2025-11-06Results of operations · Financial statements and exhibits
2025-08-06Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.